These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32712109)

  • 1. Neutrophil activation in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis of protein markers in blood and cerebrospinal fluid.
    Wu CY; Bawa KK; Ouk M; Leung N; Yu D; Lanctôt KL; Herrmann N; Pakosh M; Swardfager W
    Ageing Res Rev; 2020 Sep; 62():101130. PubMed ID: 32712109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between lipocalin-2 and mild cognitive impairment or dementia: A systematic review and meta-analysis of population-based evidence.
    Li X; Wang X; Guo L; Wu K; Wang L; Rao L; Liu X; Kang C; Jiang B; Li Q; Li H; He F; Lu C
    Ageing Res Rev; 2023 Aug; 89():101984. PubMed ID: 37330019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endosomal-Lysosomal and Autophagy Pathway in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Krance SH; Wu CY; Chan ACY; Kwong S; Song BX; Xiong LY; Ouk M; Chen MH; Zhang J; Yung A; Stanley M; Herrmann N; Lanctôt KL; Swardfager W
    J Alzheimers Dis; 2022; 88(4):1279-1292. PubMed ID: 35754279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel fluid biomarkers for mild cognitive impairment: A systematic review and meta-analysis.
    Gaur A; Rivet L; Mah E; Bawa KK; Gallagher D; Herrmann N; Lanctôt KL
    Ageing Res Rev; 2023 Nov; 91():102046. PubMed ID: 37647995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis.
    Kim BY; Lee SH; Graham PL; Angelucci F; Lucia A; Pareja-Galeano H; Leyhe T; Turana Y; Lee IR; Yoon JH; Shin JI
    Mol Neurobiol; 2017 Nov; 54(9):7297-7311. PubMed ID: 27815832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
    Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F
    Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
    Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer's disease.
    Bawa KK; Krance SH; Herrmann N; Cogo-Moreira H; Ouk M; Yu D; Wu CY; Black SE; Lanctôt KL; Swardfager W;
    J Neuroinflammation; 2020 Mar; 17(1):84. PubMed ID: 32171317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal biomarkers in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis.
    Ge YJ; Xu W; Ou YN; Qu Y; Ma YH; Huang YY; Shen XN; Chen SD; Tan L; Zhao QH; Yu JT
    Ageing Res Rev; 2021 Aug; 69():101361. PubMed ID: 34000463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
    Podhorna J; Krahnke T; Shear M; Harrison JE;
    Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered central and blood glutathione in Alzheimer's disease and mild cognitive impairment: a meta-analysis.
    Chen JJ; Thiyagarajah M; Song J; Chen C; Herrmann N; Gallagher D; Rapoport MJ; Black SE; Ramirez J; Andreazza AC; Oh P; Marzolini S; Graham SJ; Lanctôt KL
    Alzheimers Res Ther; 2022 Feb; 14(1):23. PubMed ID: 35123548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroinflammation in mild cognitive impairment and Alzheimer's disease: A meta-analysis.
    Bradburn S; Murgatroyd C; Ray N
    Ageing Res Rev; 2019 Mar; 50():1-8. PubMed ID: 30610927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory markers in Alzheimer's disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies.
    Shen XN; Niu LD; Wang YJ; Cao XP; Liu Q; Tan L; Zhang C; Yu JT
    J Neurol Neurosurg Psychiatry; 2019 May; 90(5):590-598. PubMed ID: 30630955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of CSF Aβ42 as an aid to discriminating Alzheimer's disease from other dementias and mild cognitive impairment: a meta-analysis of 50 studies.
    Tang W; Huang Q; Wang Y; Wang ZY; Yao YY
    J Neurol Sci; 2014 Oct; 345(1-2):26-36. PubMed ID: 25086857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the diagnostic value of peripheral BDNF levels for Alzheimer's disease and mild cognitive impairment: results of a meta-analysis.
    Xie B; Zhou H; Liu W; Yu W; Liu Z; Jiang L; Zhang R; Cui D; Shi Z; Xu S
    Int J Neurosci; 2020 Mar; 130(3):218-230. PubMed ID: 31518516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood and CSF chemokines in Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis.
    Zhou F; Sun Y; Xie X; Zhao Y
    Alzheimers Res Ther; 2023 Jun; 15(1):107. PubMed ID: 37291639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glial activation and inflammation along the Alzheimer's disease continuum.
    Nordengen K; Kirsebom BE; Henjum K; Selnes P; Gísladóttir B; Wettergreen M; Torsetnes SB; Grøntvedt GR; Waterloo KK; Aarsland D; Nilsson LNG; Fladby T
    J Neuroinflammation; 2019 Feb; 16(1):46. PubMed ID: 30791945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.